Groshen S - Search Results

1

Peripheral blood stem cells harvested during marrow recovery from disease-specific chemotherapy shorten duration of neutropenia in patients undergoing autologous bone marrow transplantation.

Rabinowitz AP, Watkins K, Groshen S, Chen SC, Rosen P, Mazumder A. Rabinowitz AP, et al. Among authors: groshen s. Leuk Lymphoma. 1993 Apr;9(6):485-93. doi: 10.3109/10428199309145755. Leuk Lymphoma. 1993. PMID: 8101755

2

Survival and prognostic factors in node-negative breast cancer: results of long-term follow-up studies.

Rosen PP, Groshen S, Kinne DW. Rosen PP, et al. Among authors: groshen s. J Natl Cancer Inst Monogr. 1992;(11):159-62. J Natl Cancer Inst Monogr. 1992. PMID: 1627422

3

Interleukin-2 (IL-2) and IL-2-activated bone marrow in transplantation: evaluation from a clinical perspective.

Charak BS, Agah R, Brynes RK, Chogyoji M, Groshen S, Chen SC, Mazumder A. Charak BS, et al. Among authors: groshen s. Bone Marrow Transplant. 1992 Jun;9(6):479-86. Bone Marrow Transplant. 1992. PMID: 1628133

4

Intravenous immunoglobulin in the treatment of human immunodeficiency virus-related thrombocytopenia.

Rarick MU, Montgomery T, Groshen S, Sullivan-Halley J, Jamin D, Mazumder A, Gill PS, Loureiro C, Levine AM. Rarick MU, et al. Among authors: groshen s. Am J Hematol. 1991 Dec;38(4):261-6. doi: 10.1002/ajh.2830380402. Am J Hematol. 1991. PMID: 1746533 Clinical Trial.

5

Prognosis in T2N0M0 stage I breast carcinoma: a 20-year follow-up study.

Rosen PP, Groshen S, Kinne DW. Rosen PP, et al. Among authors: groshen s. J Clin Oncol. 1991 Sep;9(9):1650-61. doi: 10.1200/JCO.1991.9.9.1650. J Clin Oncol. 1991. PMID: 1875222

6

Induction of graft versus leukemia effect in bone marrow transplantation: dosage and time schedule dependency of interleukin 2 therapy.

Charak BS, Brynes RK, Katsuda S, Groshen S, Chen SC, Mazumder A. Charak BS, et al. Among authors: groshen s. Cancer Res. 1991 Apr 15;51(8):2015-20. Cancer Res. 1991. PMID: 2009520

7

Phase I study of combination recombinant interleukin-2 and interferon gamma in patients with advanced malignancies.

Hu E, Watkins K, Groshen S, Chen SC, Malloy B, Agah R, Nichols P, Parker J, Martin A, Boosalis MG, et al. Hu E, et al. Among authors: groshen s. Mol Biother. 1990 Jun;2(2):96-103. Mol Biother. 1990. PMID: 2114123

8

Bone marrow transplantation with interleukin-2-activated bone marrow followed by interleukin-2 therapy for acute myeloid leukemia in mice.

Charak BS, Brynes RK, Groshen S, Chen SC, Mazumder A. Charak BS, et al. Among authors: groshen s. Blood. 1990 Dec 1;76(11):2187-90. Blood. 1990. PMID: 2257292 Free article.

9

Factors influencing survival and prognosis in early breast carcinoma (T1N0M0-T1N1M0). Assessment of 644 patients with median follow-up of 18 years.

Rosen PP, Groshen S. Rosen PP, et al. Among authors: groshen s. Surg Clin North Am. 1990 Aug;70(4):937-62. doi: 10.1016/s0039-6109(16)45190-x. Surg Clin North Am. 1990. PMID: 2371651

10

Nonmammary malignant neoplasms in patients with stage I (T1N0M0) and stage II (T1N1M0) breast carcinoma. A long-term follow-up study.

Rosen PP, Groshen S, Kinne DW, Hellman S. Rosen PP, et al. Among authors: groshen s. Am J Clin Oncol. 1989 Oct;12(5):369-74. doi: 10.1097/00000421-198910000-00001. Am J Clin Oncol. 1989. PMID: 2801596

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

398 results

Search Page

Filters